Doesn't look like the Daigou's are too enthusiastic. To be honest Swisse should just buy out Bellamy's, rather than wasting 100+million in advertisements.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025